What has been evaluated in randomized trials to determine the utility of monitoring hs-CRP levels?
Monitoring of hs-CRP has not been evaluated in randomized trials to determine whether it is useful in adjusting statin dose in patients who might be considered for treatment, nor has its cost-effectiveness for population screening been assessed.